🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

EPAM shares target cut by Jefferies amid growth concerns

EditorEmilio Ghigini
Published 05/10/2024, 07:44 AM
EPAM
-

On Friday, EPAM Systems (NYSE:EPAM) shares faced a reduced price target from a Jefferies, with the new target set at $202 down from $283, while the stock's rating remains at Hold. The adjustment follows a reassessment of the company's revenue prospects, shifting from an expectation of positive growth to negative.

The company's management has presented a more cautious outlook compared to previous quarters, where there was anticipation of a recovery in the second half of 2024.

Despite ongoing productive discussions with clients, immediate budgetary constraints are prioritized over investments in new technology developments.

Analysts have noted that the stock's recent market performance might be an overreaction. They suggest that the company's updated guidance has accounted for potential risks, implying that the lowered expectations may already be reflected in the stock's current valuation.

EPAM Systems' adjusted earnings per share (EPS) forecasts remain largely unchanged despite the revised revenue outlook. This indicates that while top-line growth may be under pressure, profitability measures are being maintained.

InvestingPro Insights

As EPAM Systems (NYSE:EPAM) recalibrates its growth expectations, investors may find value in recent market data and analysis. The company's market capitalization stands at a robust $10.54 billion, and with an adjusted P/E ratio of 20.89, it may appeal to value-oriented investors looking for potentially undervalued stocks. Notably, EPAM holds more cash than debt on its balance sheet, which could provide a cushion in uncertain economic times. Moreover, the stock's recent performance indicates it may be in oversold territory, with a significant price drop over the last week and month, suggesting a potential entry point for investors.

Analyzing the company's financial health, EPAM's liquid assets surpass its short-term obligations, which could be reassuring to stakeholders concerned about the firm's ability to navigate short-term challenges. Additionally, despite a downward revision in revenue growth, analysts predict EPAM will remain profitable this year, a sentiment reinforced by the company's positive profitability over the last twelve months.

For those considering a deeper dive into EPAM's financials and future prospects, InvestingPro offers a range of other metrics and insights. Explore further with a PRONEWS24 coupon code to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and discover 6 additional InvestingPro Tips that could help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.